Document Detail


Killing kinetics of five orally administered antibiotics at clinically achievable concentrations against Moraxella catarrhalis.
MedLine Citation:
PMID:  1486888     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Time-kill kinetic studies were used to measure the bactericidal activity of amoxicillin/clavulanic acid (in a new form for pediatric use), cefaclor, cefuroxime, cefixime and erythromycin against 30 beta-lactamase producing Moraxella catarrhalis strains. Antibiotics were tested at the mean maximum serum concentration observed after administration of a standard dose and at 0.5 x Cmax, 0.33 x Cmax and 0.25 x Cmax. A 2 log10 reduction in colony counts was obtained with the Cmax of amoxicillin/clavulanic acid and cefixime after 5 h of incubation. After 24 h of incubation a decrease of 3 and 4 log was observed with cefixime and amoxicillin/clavulanic acid respectively. At 0.5 x Cmax and 0.33 x Cmax, bactericidal activity was obtained only with amoxicillin/clavulanic acid.
Authors:
E Bingen; F Bourgeois; H Chardon; C Doit; N Lambert-Zechovsky
Related Documents :
17519208 - Suture biomechanics and static facial suspension.
6503228 - Liquid chromatographic determination of salicylate and methyl salicylate in blood and a...
21152098 - Identification of retinoic acid in a high content screen for agents that overcome the a...
17177748 - Superficial chemical peels.
1858698 - Fatty acid composition of subcutaneous adipose tissue and diet in postmenopausal us women.
19846108 - 12-hydroxystearic acid lipid tubes under various experimental conditions.
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology     Volume:  11     ISSN:  0934-9723     ISO Abbreviation:  Eur. J. Clin. Microbiol. Infect. Dis.     Publication Date:  1992 Oct 
Date Detail:
Created Date:  1993-02-19     Completed Date:  1993-02-19     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8804297     Medline TA:  Eur J Clin Microbiol Infect Dis     Country:  GERMANY    
Other Details:
Languages:  eng     Pagination:  923-6     Citation Subset:  IM    
Affiliation:
Service de Microbiologie, Hôpital Robert Debré, Paris, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amoxicillin / pharmacology
Amoxicillin-Potassium Clavulanate Combination
Anti-Bacterial Agents / pharmacology*
Cefaclor / pharmacology
Cefixime
Cefotaxime / analogs & derivatives,  pharmacology
Cefuroxime / pharmacology
Child
Clavulanic Acid
Clavulanic Acids / pharmacology
Colony Count, Microbial
Drug Combinations
Drug Therapy, Combination / pharmacology
Erythromycin / pharmacology
Humans
Microbial Sensitivity Tests / methods*
Moraxella (Branhamella) catarrhalis / drug effects*,  enzymology
Chemical
Reg. No./Substance:
0/Anti-Bacterial Agents; 0/Clavulanic Acids; 0/Drug Combinations; 114-07-8/Erythromycin; 26787-78-0/Amoxicillin; 53994-73-3/Cefaclor; 55268-75-2/Cefuroxime; 58001-44-8/Clavulanic Acid; 63527-52-6/Cefotaxime; 74469-00-4/Amoxicillin-Potassium Clavulanate Combination; 79350-37-1/Cefixime

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Variability of surface-exposed antigens of different strains of Moraxella catarrhalis.
Next Document:  Error rates in cefoperazone and cefoperazone-sulbactam disk tests with Enterobacteriaceae and Pseudo...